Sign in

Research summary ·

Cannabis for tic control: a systematic review and meta-analysis of its efficacy in Tourette syndrome management.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This study pooled results from earlier studies on cannabis-based drugs. It looked at people with Tourette syndrome. Tourette syndrome causes tics, which are sudden movements or sounds. The team searched several research databases up to July 2, 2025. They looked for trials and for studies that followed groups of patients. They then compared tic scores before and after treatment.

What they found

The team screened 1,105 articles. The pooled data covered 306 adults with Tourette syndrome. After treatment, tic scores were lower than before. On the main tic scale, scores fell by 13.29 points on average. Scores for the urge felt before a tic fell by 4.09 points. Both drops were judged unlikely to be due to chance.

What it means for patients

The authors say cannabis-based drugs may help reduce tics. These drugs may also lessen the urge people feel before a tic. The authors call for larger trials to confirm this. Such trials would also check safety and find the right dose.

Why it is not certain yet

The abstract says the evidence so far is limited. The pooled data came from 306 adults. Scores were compared before and after treatment, not against a dummy drug. The abstract gives no safety results. A review can only be as good as the studies in it.

Source

Cannabis for tic control: a systematic review and meta-analysis of its efficacy in Tourette syndrome management.

PubMed · PMID 42229830

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Tourette syndrome publications